A Pilot Trial of a Smartphone-based Self-management Support Program for COPD Patients
A Pilot Trial of a Smartphone-based Self-management Support Program for Patients With Chronic Obstructive Pulmonary Disease
COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.
The current proposal is to evaluate the feasibility and acceptability of a pilot trial of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.
研究概览
详细说明
Chronic obstructive pulmonary disease (COPD) is the number 3 killer globally by 2020. COPD patients often experience multiple symptoms (e.g. dyspnea, cough, and deteriorating quality of life) and have imposed a substantial economic and social burden on health care.
Current policy for the prevention and management of long-term conditions focuses on efforts to prevent the onset or slow progression of disease early in the disease trajectory. This prevention paradigm has only recently been adopted for COPD. Systematic reviews have shown self-management support for patients with COPD is effective in improving health-related quality of life and in reducing hospital admissions, but the evidence comes largely from patients with moderate or severe disease and is predominantly recruited from secondary care. Simple and systematic strategies are needed to improve out-of-hospital support and management for people living with COPD.
An instant messaging smartphone app, which allows texts, audio, pictures and video messages to be shared in chat groups, is already available to and is the most popular in the Hong Kong general public. Mobile instant messaging can be conducted through a daily use device to increase access and efficacy, which has been suggested as a feasible approach to delivering an intervention with positive effects on health behaviours and outcomes. Text messaging via mobile phones has been shown to be effective in helping promote lifestyle change in diabetes self-management, weight loss, physical activity, smoking cessation and medication adherence with quantitative and qualitative evidence. However, the investigator has not found messaging intervention that was applied in people with COPD, except an ongoing study of using instant text message support for patients with chronic respiratory and cardiovascular diseases.
Hence, the current intervention program is to evaluate the feasibility and acceptability of a smartphone-based instant messaging self-management support program to improve the quality of life in patients with COPD.
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Asa Choi, MA
- 电话号码:852-3917-6563
- 邮箱:asachoi@hku.hk
研究联系人备份
- 姓名:Agnes YK Lai, PhD
- 电话号码:852-3917-6328
- 邮箱:agneslai@hku.hk
学习地点
-
-
-
Hong Kong、香港、852
- 招聘中
- Queen Mary Hospital
-
接触:
- David Lam, PhD
- 电话号码:2255-4455
- 邮箱:slnga@hku.hk
-
接触:
- Agnes Lai, PhD
- 电话号码:93176779
- 邮箱:agneslai@hku.hk
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion criteria
- Aged 18 years and above
- Diagnosis with COPD
- General condition stable
- Able to speak and read Chinese
- Able to complete the self-administered questionnaire
- Able to use instant messages such as WhatsApp or WeChat
- Mental, cognitive and physically fit for joining the trial as determined by the clinician or responsible investigator
- Signed informed consent
Exclusion criteria
- Skeletal fragility
- Serious active infection
- Inability to walk
- Severe respiratory insufficiency
学习计划
研究是如何设计的?
设计细节
- 主要用途:支持治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Intervention group
The intervention group will receive a smartphone-based self-management support programme, including a 30-min face-to-face or online session at baseline, 3 phone calls (week 2, week 4 and week 6) and 2-month mobile messages in addition to usual care.
|
A smartphone-based self-management support programme includes a 30-min face-to-face or online session at baseline, 3 phone calls and 2-month mobile messages
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline COPD-related quality of life
大体时间:Baseline, Week 8
|
COPD symptoms and impacts and activity level were measured by an 8-item COPD Assessment Test.
Total scores range from 0 to 40, with higher scores denoting a more severe impact of COPD on a patient's life.
|
Baseline, Week 8
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change from baseline patient activation
大体时间:Baseline, Week 8
|
Knowledge, skills and confidence in self-management were measured by a 13-item Patient Activation Measure Scale.
The total score ranges from 0 (no activation) to 100 (high activation), with higher scores denoting the better patient activation.
|
Baseline, Week 8
|
|
Change from baseline self-efficacy for self-management
大体时间:Baseline, Week 8
|
Confidence and perceived ability of self-care were measured by a 6-item Stanford self-efficacy scale.
The score for each item ranges from 1 (not at all confident) to 10 (totally confident).
The total score of the scale is the mean of the six items, with higher number indicates higher self-efficacy.
|
Baseline, Week 8
|
|
Change from baseline acceptance of illness
大体时间:Baseline, Week 8
|
Acceptance of illness measured by a 8-item acceptance of illness scale.
Each item ranges from 1 to 5. The total score of the scale is between 8 and 40, with low score showing a lack of adjustment to the disease, no acceptance of the condition, and mental discomfort, while high score indicating good disease acceptance.
|
Baseline, Week 8
|
|
Change from baseline medication adherence
大体时间:Baseline, Week 8
|
Medication adherence measured by a 4-item Morisky Medication-Taking Adherence Scale.
The scale consists of four items with a scoring scheme of "Yes" = 0 and "No" = 1.
All items are summed to give a range of scores from 0 to 4, with higher score indicating a low level of medication adherence.
|
Baseline, Week 8
|
|
Change from baseline physical activity level
大体时间:Baseline, Week 8
|
Physical activity measured by a 7-item International Physical Activity Questionnaire-short form.
Number of days and duration (in hours and minutes) engaging in vigorous activities, moderate activities, and walking in past 7 days will be collected.
Duration (in hours and minutes) of sitting time on week days and weekends will be collected.
|
Baseline, Week 8
|
|
Change from dyspnea severity
大体时间:Baseline, week 8
|
Dyspnea severity measured by a 1-item MRC dyspnea scale.
The scale consists of five statements about perceived breathlessness: grade 1, "I only get breathless with strenuous exercise"; grade 2, "I get short of breath when hurrying on the level or up a slight hill"; grade 3, "I walk slower than people of the same age on the level because of breathlessness or have to stop for breath when walking at my own pace on the level"; grade 4, "I stop for breath after walking 100 yards or after a few minutes on the level"; grade 5, " I am too breathless to leave the house".
Patients selected the grade that applied to them.
|
Baseline, week 8
|
|
Change from baseline Health status
大体时间:Baseline, Week 8
|
Health status measured by a 5-item EuroQol 5-Dimension questionnaire.
The scale comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension was scored by five levels, with 1 representing no problem and 5 representing extreme problem.
|
Baseline, Week 8
|
|
Change from anxiety and depressive symptoms
大体时间:Baseline, Week 8
|
Anxiety and depressive symptoms measured by a 14-item Hospital Anxiety and Depression Scale.
Each item ranges from 0-3.
The total scores of both Anxiety and Depression subscales range from 0-21, with higher scores indicating higher level of anxiety and depression respectively.
|
Baseline, Week 8
|
|
Change in baseline social support
大体时间:Baseline, Week 8
|
Social support measured by a 6-item Multidimensional Scale of Perceived Social Support.
Each item ranges from 1 (very strongly disagree) to 7 (very strongly agree).
The total score is the sum across all items divided by 6, with higher score indicating more social support.
|
Baseline, Week 8
|
|
Change in from baseline sleep quality
大体时间:Baseline, Week 8
|
Sleep quality measured by a 7-item Insomnia Severity Index.
The total score range from 0 (absence of insomnia) to 28 (severe insomnia).
|
Baseline, Week 8
|
|
Change in baseline grip strength
大体时间:Baseline, Week 8
|
Grip strength of both hands measured by dynamometer
|
Baseline, Week 8
|
|
Change in baseline balance
大体时间:Baseline, Week 8
|
Balance assessed by a single-leg stance test.
|
Baseline, Week 8
|
合作者和调查者
出版物和有用的链接
一般刊物
- Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health. 2015 Mar 18;36:393-415. doi: 10.1146/annurev-publhealth-031914-122855.
- Buttery SC, Zysman M, Vikjord SAA, Hopkinson NS, Jenkins C, Vanfleteren LEGW. Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity. Respirology. 2021 May;26(5):419-441. doi: 10.1111/resp.14032. Epub 2021 Mar 9.
- Jolly K, Sidhu MS, Hewitt CA, Coventry PA, Daley A, Jordan R, Heneghan C, Singh S, Ives N, Adab P, Jowett S, Varghese J, Nunan D, Ahmed K, Dowson L, Fitzmaurice D. Self management of patients with mild COPD in primary care: randomised controlled trial. BMJ. 2018 Jun 13;361:k2241. doi: 10.1136/bmj.k2241.
- Redfern J, Hyun K, Singleton A, Hafiz N, Raeside R, Spencer L, Carr B, Caterson I, Cullen J, Ferry C, Santo K, Hayes A, Leung RWM, Raadsma S, Swinbourne J, Cho JG, King M, Roberts M, Kok C, Jenkins C, Chow C. ITM support for patients with chronic respiratory and cardiovascular diseases: a protocol for a randomised controlled trial. BMJ Open. 2019 Mar 1;9(3):e023863. doi: 10.1136/bmjopen-2018-023863.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.